News
National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide Patients were eligible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback